By the age of 4, Matthew Haemsch had undergone 16 rounds of chemotherapy and a surgery to remove a cancerous tumor on his adrenal gland. Yet, his small body remained riddled with a rare pediatric cancer.
University of California, San Diego School of Medicine’s Rob Knight, PhD, and his team built a microbiome analysis platform called QIIME (pronounced “chime” and short for “Quantitative Insights Into Microbial Ecology”). This software will now be more readily accessible to hundreds of thousands of researchers around the world through BaseSpace, a cloud-based app store offered by Illumina, a San Diego-based company that develops life science tools for the analysis of genetic variation.
The University of California, San Diego is named the 19th best university in the world in U.S. News and World Report’s second-annual global rankings, released today. The campus is one of only five public universities in the U.S. to make the top 20 in the list of the world’s top 750 colleges. The rankings measure factors such as research, global and regional reputation, international collaboration as well as number of highly-cited papers and doctorates awarded. The U.S. News Best Global Universities 2016 edition also features 22 subject rankings, in which UC San Diego received high marks for its academic areas, such as pharmacology and toxicology (4), neuroscience and behavior (6), biology and biochemistry (6), psychiatry and psychology (7), computer science (9), as well as molecular biology and genetics (10).
Four professors at UC San Diego will receive New Innovator Awards from the National Institutes of Health of approximately $2.2 million over the next five years to support their “unusually innovative research,” the NIH announced today.
The new documentary “HIV/SIDA: The Epidemic in Tijuana” offers an unflinching look at the challenges facing researchers from the University of California, San Diego as they attempt to identify and treat people who inject drugs, sex workers, transgender women and others who are at high risk for HIV infection in Tijuana.
Under its new 4D Nucleome Program, the National Institutes of Health (NIH) Common Fund has awarded three grants totaling more than $30 million over five years to multidisciplinary teams of researchers at University of California, San Diego.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
